Ikarian Capital, LLC Novavax Inc Call Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $3.39 Million - $5.42 Million	706,068 Added 9900.0%	713,200 $3.42 Million
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $2.68 Million - $3.83 Million	-392,868 Reduced 98.22%	7,132 $51,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $2.67 Million - $3.81 Million	400,000 New	400,000 $2.97 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $7.91 Million - $22.4 Million	70,000 New	70,000 $12.7 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.